IDEXX Laboratories Inc
NASDAQ:IDXX

Watchlist Manager
IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc
NASDAQ:IDXX
Watchlist
Price: 413.62 USD 0.11%
Market Cap: 33.9B USD
Have any thoughts about
IDEXX Laboratories Inc?
Write Note

IDEXX Laboratories Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IDEXX Laboratories Inc
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
IDEXX Laboratories Inc
NASDAQ:IDXX
Net Income (Common)
$866.2m
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
16%
Becton Dickinson and Co
NYSE:BDX
Net Income (Common)
$1.7B
CAGR 3-Years
-5%
CAGR 5-Years
10%
CAGR 10-Years
4%
Boston Scientific Corp
NYSE:BSX
Net Income (Common)
$1.8B
CAGR 3-Years
18%
CAGR 5-Years
10%
CAGR 10-Years
20%
Stryker Corp
NYSE:SYK
Net Income (Common)
$3.6B
CAGR 3-Years
24%
CAGR 5-Years
1%
CAGR 10-Years
19%
Abbott Laboratories
NYSE:ABT
Net Income (Common)
$5.8B
CAGR 3-Years
-7%
CAGR 5-Years
12%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Net Income (Common)
$2.2B
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
18%
No Stocks Found

IDEXX Laboratories Inc
Glance View

Market Cap
34B USD
Industry
Health Care
Economic Moat
Narrow

IDEXX Laboratories Inc. stands as a pillar of innovation in the realm of veterinary diagnostics, transforming the landscape of animal healthcare. Founded in 1983, the company has strategically positioned itself at the intersection of science and care, delivering a broad range of products and services that cater primarily to veterinarians. By offering state-of-the-art diagnostic tests and in-house laboratory equipment, IDEXX empowers veterinarians to make precise and timely decisions. These tools not only enhance animal health but also streamline veterinary practices, allowing them to offer clients rapid, reliable results. By investing heavily in research and development, IDEXX continuously enhances its product portfolio, maintaining a competitive edge in a market that demands constant innovation. In addition to its core veterinary diagnostic services, IDEXX extends its expertise into water testing and livestock and poultry diagnostics, though these segments are smaller. The company crafts its revenue model on providing recurring, subscription-based services for its diagnostic machines, which require regular updating with new test kits and consumables. This model ensures a durable revenue stream, fostering long-term relationships with veterinary clinics worldwide. As digital transformation sweeps through every industry, IDEXX has also embraced the digital age, crafting sophisticated software that aids veterinarians in managing their practices more efficiently, thus augmenting its revenue through IT solutions. This diversified yet synergistic approach has allowed IDEXX to remain resilient and grow steadily, delivering consistent value to both its clients and shareholders.

IDXX Intrinsic Value
254.13 USD
Overvaluation 39%
Intrinsic Value
Price

See Also

What is IDEXX Laboratories Inc's Net Income (Common)?
Net Income (Common)
866.2m USD

Based on the financial report for Sep 30, 2024, IDEXX Laboratories Inc's Net Income (Common) amounts to 866.2m USD.

What is IDEXX Laboratories Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
16%

Over the last year, the Net Income (Common) growth was 5%. The average annual Net Income (Common) growth rates for IDEXX Laboratories Inc have been 5% over the past three years , 15% over the past five years , and 16% over the past ten years .

Back to Top